- £795.53m
- £795.51m
- -£39.79m
- 51
- 77
- 53
- 66
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.66 | ||
| Price to Tang. Book | 0.66 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | -5.51 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -13.74% | ||
| Return on Equity | -12.88% | ||
| Operating Margin | 114.48% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 439.12 | -167.31 | 78.54 | 18.69 | -39.79 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +130.47 | n/a | n/a | -83.44 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Syncona Limited is a Guernsey-based closed-ended investment company. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership) in which the Company is the sole limited partner. The general partner of the Partnership is Syncona GP Limited (the General Partner), a wholly owned subsidiary of the Company. Syncona Investment Management Limited is its alternative investment manager.
Directors
- Melanie Gee NEC
- Martin Murphy CEX
- Freddie Dear OTH
- Kenneth Galbraith OTH (59)
- Gonzalo Garcia OTH
- Alex Hamilton OTH
- Edward Hodgkin OTH
- Christopher Hollowood OTH
- Markus John OTH
- Magdalena Jonikas OTH
- Michael Kyriakides OTH
- Lorenz Mayr OTH
- Elisa Petris OTH
- Alice Renard OTH
- Dominic Schmidt OTH
- Fiona Smith OTH
- Rolf Soderstrom OTH (55)
- Hitesh Thakrar OTH
- Julie Cherrington NED
- Cristina Csimma NED (62)
- Thomas Henderson NID
- Virginia Holmes NID
- Robert Hutchinson NID
- Kemal Malik NID (59)
- Gian Reverberi NID
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- August 14th, 2012
- Public Since
- October 26th, 2012
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
London Stock Exchange- Shares in Issue
- 654,215,586
- Address
- Arnold House, St Julian's Avenue,, SAINT PETER PORT, GY1 3RD
- Web
- https://www.synconaltd.com/
- Phone
- Auditors
- Deloitte LLP
Latest News for SYNC
Upcoming Events for SYNC
Full Year 2024 Syncona Ltd Earnings Release
Syncona Ltd Annual Shareholders Meeting
Similar to SYNC
ACG Acquisition
London Stock Exchange
Acp Energy
London Stock Exchange
Admiral Acquisition
London Stock Exchange
Ajax Resources
London Stock Exchange
Alteration Earth
London Stock Exchange
FAQ
As of Today at 19:21 UTC, shares in Syncona are trading at 121.60p. This share price information is delayed by 15 minutes.
Shares in Syncona last closed at 121.60p and the price had moved by -20% over the past 365 days. In terms of relative price strength the Syncona share price has underperformed the FTSE All Share Index by -21.38% over the past year.
The overall consensus recommendation for Syncona is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Syncona does not currently pay a dividend.
Syncona does not currently pay a dividend.
Syncona does not currently pay a dividend.
To buy shares in Syncona you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 121.60p, shares in Syncona had a market capitalisation of £795.53m.
Here are the trading details for Syncona:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: SYNC
Based on an overall assessment of its quality, value and momentum Syncona is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Syncona is 245.33p. That is 101.75% above the last closing price of 121.60p.
Analysts covering Syncona currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Syncona. Over the past six months, its share price has underperformed the FTSE All Share Index by -8.87%.
As of the last closing price of 121.60p, shares in Syncona were trading -5.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Syncona PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 121.60p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Syncona's management team is headed by:
- Melanie Gee - NEC
- Martin Murphy - CEX
- Freddie Dear - OTH
- Kenneth Galbraith - OTH
- Gonzalo Garcia - OTH
- Alex Hamilton - OTH
- Edward Hodgkin - OTH
- Christopher Hollowood - OTH
- Markus John - OTH
- Magdalena Jonikas - OTH
- Michael Kyriakides - OTH
- Lorenz Mayr - OTH
- Elisa Petris - OTH
- Alice Renard - OTH
- Dominic Schmidt - OTH
- Fiona Smith - OTH
- Rolf Soderstrom - OTH
- Hitesh Thakrar - OTH
- Julie Cherrington - NED
- Cristina Csimma - NED
- Thomas Henderson - NID
- Virginia Holmes - NID
- Robert Hutchinson - NID
- Kemal Malik - NID
- Gian Reverberi - NID